Widening the Therapeutic Window in the Management of Parkinson’s Disease

Author(s):

Stuart H. Isaacson, MD, FAAN,Rajesh Pahwa, MD

Expert neurologists discuss strategies to widen the therapeutic window of Parkinson’s disease and options available to treat dyskinesia, providing better control of Parkinson’s disease.

To watch the full video episode, follow this link.

1:12 Long-term challenges

4:00 Levodopa fluctuations

6:30 Therapeutic window

9:20 Amantadine DR/ER for PD

11:30 Dyskinesia treatment

18:10 Amantadine candidates

23:34 PK of amantadine

27:15 Early treatment

Now Viewing

EP: 1.Widening the Therapeutic Window in the Management of Parkinson’s Disease

EP: 2.Widening the Therapeutic Window in The Management of Parkinson’s Disease

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Subscribe Now!

Widening the Therapeutic Window in the Management of Parkinson’s Disease

EP: 1.Widening the Therapeutic Window in the Management of Parkinson’s Disease

EP: 2.Widening the Therapeutic Window in The Management of Parkinson’s Disease

Newsletter